Drug therapies for peripheral joint disease in psoriatic arthritis: a systematic review

Maria Laura Acosta Felquer; Laura C Coates; Enrique R Soriano; Roberto Ranza; Luis R Espinoza; Philip S Helliwell; Oliver FitzGerald; Neil McHugh; Euthalia Roussou; Philip J Mease

doi:10.3899/jrheum.140876

Drug therapies for peripheral joint disease in psoriatic arthritis: a systematic review

Maria Laura Acosta Felquer, Laura C Coates, Enrique R Soriano, Roberto Ranza, Luis R Espinoza, Philip S Helliwell, Oliver FitzGerald, Neil McHugh, Euthalia Roussou, Philip J Mease

Research output: Contribution to journal › Article › peer-review

47 Citations (SciVal)

225 Downloads (Pure)

Abstract

In 2009, GRAPPA published their first evidence-based recommendations for the treatment of psoriasis and psoriatic arthritis (PsA). Since then, new information has been published and drugs developed. We summarize evidence for the efficacy of available treatments for peripheral joint involvement in PsA. We performed a systematic review of current literature on the efficacy of different therapies, management, and therapeutic strategies for peripheral arthritis involvement in PsA, in order to provide information for the development of the new GRAPPA treatment recommendations.

Original language	English
Pages (from-to)	2277-2285
Number of pages	9
Journal	The Journal of Rheumatology
Volume	41
Issue number	11
DOIs	https://doi.org/10.3899/jrheum.140876
Publication status	Published - Nov 2014

Access to Document

10.3899/jrheum.140876

Drug therapies for peripheral joint disease
This is a pre-copy-editing, author-produced PDF of an article accepted for publication in The Journal of Rheumatology following peer review. The definitive publisher-authenticated version Acosta Felquer, ML, Coates, LC, Soriano, ER, Ranza, R, Espinoza, LR, Helliwell, PS, FitzGerald, O, McHugh, N, Roussou, E & Mease, PJ 2014, 'Drug therapies for peripheral joint disease in psoriatic arthritis: a systematic review' The Journal of Rheumatology, vol 41, no. 11, pp. 2277-2285 is available online at: http://dx.doi.org/10.3899/jrheum.140876
Submitted manuscript, 496 KB

Cite this

@article{8d167ccac61e4b8f929466738d11d045,

title = "Drug therapies for peripheral joint disease in psoriatic arthritis: a systematic review",

abstract = "In 2009, GRAPPA published their first evidence-based recommendations for the treatment of psoriasis and psoriatic arthritis (PsA). Since then, new information has been published and drugs developed. We summarize evidence for the efficacy of available treatments for peripheral joint involvement in PsA. We performed a systematic review of current literature on the efficacy of different therapies, management, and therapeutic strategies for peripheral arthritis involvement in PsA, in order to provide information for the development of the new GRAPPA treatment recommendations.",

author = "{Acosta Felquer}, {Maria Laura} and Coates, {Laura C} and Soriano, {Enrique R} and Roberto Ranza and Espinoza, {Luis R} and Helliwell, {Philip S} and Oliver FitzGerald and Neil McHugh and Euthalia Roussou and Mease, {Philip J}",

year = "2014",

month = nov,

doi = "10.3899/jrheum.140876",

language = "English",

volume = "41",

pages = "2277--2285",

journal = "The Journal of Rheumatology",

issn = "0315-162X",

publisher = "Journal of Rheumatology",

number = "11",

}

TY - JOUR

T1 - Drug therapies for peripheral joint disease in psoriatic arthritis

T2 - a systematic review

AU - Acosta Felquer, Maria Laura

AU - Coates, Laura C

AU - Soriano, Enrique R

AU - Ranza, Roberto

AU - Espinoza, Luis R

AU - Helliwell, Philip S

AU - FitzGerald, Oliver

AU - McHugh, Neil

AU - Roussou, Euthalia

AU - Mease, Philip J

PY - 2014/11

Y1 - 2014/11

N2 - In 2009, GRAPPA published their first evidence-based recommendations for the treatment of psoriasis and psoriatic arthritis (PsA). Since then, new information has been published and drugs developed. We summarize evidence for the efficacy of available treatments for peripheral joint involvement in PsA. We performed a systematic review of current literature on the efficacy of different therapies, management, and therapeutic strategies for peripheral arthritis involvement in PsA, in order to provide information for the development of the new GRAPPA treatment recommendations.

AB - In 2009, GRAPPA published their first evidence-based recommendations for the treatment of psoriasis and psoriatic arthritis (PsA). Since then, new information has been published and drugs developed. We summarize evidence for the efficacy of available treatments for peripheral joint involvement in PsA. We performed a systematic review of current literature on the efficacy of different therapies, management, and therapeutic strategies for peripheral arthritis involvement in PsA, in order to provide information for the development of the new GRAPPA treatment recommendations.

UR - http://dx.doi.org/10.3899/jrheum.140876

U2 - 10.3899/jrheum.140876

DO - 10.3899/jrheum.140876

M3 - Article

C2 - 25362711

SN - 0315-162X

VL - 41

SP - 2277

EP - 2285

JO - The Journal of Rheumatology

JF - The Journal of Rheumatology

IS - 11

ER -

Drug therapies for peripheral joint disease in psoriatic arthritis: a systematic review

Abstract

Access to Document

Other files and links

Fingerprint

Cite this